Obsessive-compulsive disorder (OCD) is a debilitating condition, with up to 20% of patients being refractory to medical treatment. For these severe cases, neuromodulatory techniques targeting distinct brain areas have been successful. In this work, we used normative functional connectomics to identify the brain network underlying symptom improvement in OCD. A pan-modality efficacy map identified cortical and subcortical areas as key regions, and this specific network could be used to successfully predict clinical improvement. These results suggest that symptom reduction following neuromodulation involves the engagement of a common functional network that could be investigated as a biomarker of treatment success.
No takes yet. Share an insight, caveat, or question.
Germann et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: